The Effect of Temperament on the Association Between Pre-treatment Anxiety and Chemotherapy-Related Symptoms in Patients With Breast Cancer

다국어 초록 (Multilingual Abstract)

Objective Pre-treatment anxiety (PA) before chemotherapy increases complaints of chemotherapy-related symptoms (CRS). The results on the association have been inconsistent, and the effect of temperament remains unclear. We aimed to determine whether PA is a risk factor for CRS and the effect of differing temperaments on CRS.Methods This prospective study comprised 176 breast cancer patients awaiting adjuvant chemotherapy post-surgery. We assessed CRS, PA, and temperament using the MD Anderson Symptom Inventory (MDASI), the Hospital Anxiety and Depression Scale, and the short form of the Temperament and Character Inventory-Revised, respectively. The MDASI was re-administered three weeks after the first chemo-cycle.Results PA showed weak positive correlation with several CRS after the first cycle; no CRS was significantly associated with PA when pre-treatment depressive symptoms and baseline CRS were adjusted in multiple regression analysis. Moderation model analysis indicated that the PA effect on several CRS, including pain, insomnia, anorexia, dry mouth, and vomiting, was moderated by harm avoidance (HA) but not by other temperament dimensions. In particular, PA was positively associated with CRS in patients with low HA.Conclusion The results in patients with low HA indicate that more attention to PA in patients with confident and optimistic temperaments is necessary.

참고문헌 (Reference)

• 1 Whitford HS, "When expectations predict experience: the influence of psychological factors on chemotherapy toxicities" 43 : 1036-1050, 2012
• 2 Lockefeer JP, "What is the relationship between trait anxiety and depressive symptoms, fatigue, and low sleep quality following breast cancer surgery?" 22 : 1127-1133, 2013
• 3 Yun YH, "Validation study of the Korean version of the M. D. Anderson Symptom Inventory" 31 : 345-352, 2006
• 4 Schneider A, "Trajectories and predictors of state and trait anxiety in patients receiving chemotherapy for breast and colorectal cancer: results from a longitudinal study" 24 : 1-7, 2016
• 5 Van Esch L, "Trait anxiety predicts disease-specific health status in early-stage breast cancer patients" 20 : 865-873, 2011
• 6 Bjelland I, "The validity of the hospital anxiety and depression scale: an updated literature review" 52 : 69-77, 2002
• 7 Mendoza TR, "The validity and utility of the M. D. Anderson Symptom Inventory in patients with breast cancer: evidence from the symptom outcomes and practice patterns data from the eastern cooperative oncology group" 13 : 325-334, 2013
• 8 Cloninger CR, "The temperament and character inventory (TCI): a guide to its development and use"
• 9 Ream E, "The role of information in patients’ adaptation to chemotherapy and radiotherapy: a review of the literature" 5 : 132-138, 1996
• 10 Peirson AR, "The relationship between personality and mood: comparison of the BDI and the TCI" 30 : 391-399, 2001
• 11 Ancoli-Israel S, "The relationship between fatigue and sleep in cancer patients: a review" 10 : 245-255, 2001
• 12 Zigmond AS, "The hospital anxiety and depression scale" 67 : 361-370, 1983
• 13 Dranitsaris G, "The development of a prediction tool to identify cancer patients at high risk for chemotherapy-induced nausea and vomiting" 28 : 1260-1267, 2017
• 14 Heath AC, "Testing a model for the genetic structure of personality: a comparison of the personality systems of Cloninger and Eysenck" 66 : 762-775, 1994
• 15 Min BB, "Temperament and character inventory-family manual" Maumsarang 2007
• 16 Grassi L, "Role of psychosocial variables on chemotherapy-induced nausea and vomiting and health-related quality of life among cancer patients: a European study" 84 : 339-347, 2015
• 17 Watson M, "Psychological factors predicting nausea and vomiting in breast cancer patients on chemotherapy" 34 : 831-837, 1998
• 18 Molassiotis A, "Pretreatment factors predicting the development of postchemotherapy nausea and vomiting in Chinese breast cancer patients" 10 : 139-145, 2002
• 19 Clarke P, "Prepared for the worst: readiness to acquire threat bias and susceptibility to elevate trait anxiety" 8 : 47-57, 2008
• 20 Van Der Pligt J, "Perceived risk and vulnerability as predictors of precautionary behaviour" 3 : 1-14, 1998
• 21 Jovančević A, "Optimism-pessimism, conspiracy theories and general trust as factors contributing to COVID-19 related behavior - A cross-cultural study" 167 : 110216-, 2020
• 22 Schwarzer R, "Optimism, vulnerability, and self-beliefs as health-related cognitions: a systematic overview" 9 : 161-180, 1994
• 23 Griffin AM, "On the receiving end. V: patient perceptions of the side effects of cancer chemotherapy in 1993" 7 : 189-195, 1996
• 24 Hoang HTX, "New-onset insomnia among cancer patients undergoing chemotherapy:prevalence, risk factors, and its correlation with other symptoms" 24 : 241-251, 2020
• 25 Aiken LS, "Multiple regression: testing and interpreting interactions" Sage 1991
• 26 Hayes AF, "Introduction to mediation, moderation, and conditional process analysis: a regression-based approach" Guilford Press 2013
• 27 Hirano S, "Evaluating the state dependency of the temperament and character inventory dimensions in patients with major depression: a methodological contribution" 69 : 31-38, 2002
• 28 Boz C, "Effect of serotonergic antidepressant therapy on temperament and character scales in patients with chronic tension-type headache" 61 : 534-542, 2007
• 29 Marchesi C, "Effect of pharmacological treatment on temperament and character in panic disorder" 158 : 147-154, 2008
• 30 Molassiotis A, "Development and preliminary validation of a risk prediction model for chemotherapy-related nausea and vomiting" 21 : 2759-2767, 2013
• 31 Goth K, "Das Temperament und Charakter Inventar Kurzversion für Erwachsene - TCI R Kurz"
• 32 Fernández-Ortega P, "Chemotherapy-induced nausea and vomiting in clinical practice: impact on patients’ quality of life" 20 : 3141-3148, 2012
• 33 Wirtz PW, "Anxiety effects on disaster precautionary behaviors: a multi-path cognitive model" 24 : 1401-1411, 2019
• 34 Jacobsen PB, "Anticipatory anxiety in women receiving chemotherapy for breast cancer" 12 : 469-475, 1993
• 35 Kautio AL, "Amitriptyline in the treatment of chemotherapy-induced neuropathic symptoms" 35 : 31-39, 2008
• 36 Partridge AH, "Adherence and persistence with oral adjuvant chemotherapy in older women with early-stage breast cancer in CALGB 49907: adherence companion study 60104" 28 : 2418-2422, 2010
• 37 Cloninger CR, "A unified biosocial theory of personality and its role in the development of anxiety states" 4 : 167-226, 1986
• 38 Cloninger CR, "A psychobiological model of temperament and character" 50 : 975-990, 1993
• 39 Ho SY, "A longitudinal study of depression, fatigue, and sleep disturbances as a symptom cluster in women with breast cancer" 49 : 707-715, 2015
• 40 Oh SM, "A comparison of normal, depressed and anxious groups: a study on the standardization of the hospital anxiety and depressed scale for Koreans" 38 : 289-296, 1999